VIJAYA · Healthcare · Diagnostics & Research
Composite scorecard: 58/100 — Quality 74 · Valuation 7 · Growth 64 · Momentum 94
| Share price | ₹1,334.70 |
| Market cap | ₹10,336 Cr |
| P/E ratio | 64.9 |
| P/B ratio | 11.9 |
| ROCE | 19.2% |
| Dividend yield | 0.20% |
| Book value | ₹84.14 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹814 Cr | ₹173 Cr | 41.0% |
| 2025 | ₹681 Cr | ₹144 Cr | 40.0% |
| 2024 | ₹548 Cr | ₹120 Cr | 40.0% |
| 2023 | ₹459 Cr | ₹85 Cr | 40.0% |
| 2022 | ₹462 Cr | ₹111 Cr | 44.0% |
Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T services. It also provides health checkups and home sample collection services. Vijaya Diagnostic Centre Limited was founded in 1981 and is based in Hyderabad, India.